CAMBRIDGE, Mass., Sep 09, 2010 (BUSINESS WIRE) -- Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Morgan
Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at
1:35 p.m. Eastern Time at the Grand Hyatt New York in New York City.
A live webcast of Ironwood's presentation will be accessible through the
Investors section of the company's website at www.ironwoodpharma.com.
To access the webcast, please log on to the Ironwood website
approximately 15 minutes prior to the start of the presentation to
ensure adequate time for any software downloads that may be required. A
replay of the webcast will be available on Ironwood's website for 14
days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is being evaluated in
a confirmatory Phase 3 program for the treatment of irritable bowel
syndrome with constipation (IBS-C) and chronic constipation. Ironwood
also has a growing pipeline of additional drug candidates in earlier
stages of development. Ironwood is located in Cambridge, Mass.
SOURCE: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals
Susan Brady, 617-621-8304
Corporate Communications
[email protected]
Copyright Business Wire 2010